FCF Margin % is calculated as Free Cash Flow divided by its Revenue. RenovaCare's Free Cash Flow for the
three
months ended in Sep. 2022 was $-0.15 Mil. RenovaCare's Revenue for the
three
months ended in Sep. 2022 was $0.00 Mil. Therefore, RenovaCare's FCF Margin % for the quarter that ended in Sep. 2022 was 0.00%.
The historical rank and industry rank for RenovaCare's FCF Margin % or its related term are showing as below:
RCAR's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -148.935 * Ranked among companies with meaningful FCF Margin % only.
RenovaCare FCF Margin % Historical Data
The historical data trend for RenovaCare's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of RenovaCare's FCF Margin %
For the Biotechnology subindustry, RenovaCare's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RenovaCare's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, RenovaCare's FCF Margin % distribution charts can be found below:
* The bar in red indicates where RenovaCare's FCF Margin % falls into.
RenovaCare FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
RenovaCare's FCF Margin for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RenovaCare FCF Margin % Related Terms
Thank you for viewing the detailed overview of RenovaCare's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
RenovaCare Inc is a biotechnology company focusing on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The company's initial products under development target skin. It offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). RenovaCare is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma. Geographically all the activities are functioned through the region of United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RCAR has been successfully added to your 